TAURIGA SCIENCES, INC. (80)
Browse by Contract Category
Contracts
-
Lease agreement for corporate headquarters dated January 6, 2021
(Filed With SEC on January 8, 2021)
-
Master Services Agreement between the Company and Clinical Strategies & Tactics, Inc., dated December 16, 2020
(Filed With SEC on December 29, 2020)
-
Promissory Note between the Company and Tangiers Global, LLC consummated on December 21, 2020
(Filed With SEC on December 29, 2020)
-
License Agreement between Think Big, LLC and Tauriga Sciences, Inc., dated September 24, 2020
(Filed With SEC on October 1, 2020)
-
Consulting Agreement, dated July 15, 2020, by and between the Company and Dr. Keith Aqua
(Filed With SEC on July 22, 2020)
-
Mr. Checkout distributor agreement dated June 29, 2020
(Filed With SEC on July 14, 2020)
-
Joint Venture Partnership agreement between the Company and OG Labratories, LLC dated January 21, 2020
(Filed With SEC on February 13, 2020)
-
Amendment to Registration Rights Agreement, dated November 18, 2020
(Filed With SEC on November 19, 2020)
-
Amendment to Investment Agreement, dated November 18, 2020
(Filed With SEC on November 19, 2020)
-
Inventory Financing Promissory Note for $135,000 dated October 5, 2020 with Jefferson St. Capital LLC
(Filed With SEC on November 16, 2020)
-
Securities Purchase Agreement with Jefferson Street Capital, LLC date October 5, 2020
(Filed With SEC on November 16, 2020)
-
Form of Private Placement Stock sale agreements for shares issued and funds received
(Filed With SEC on November 16, 2020)
-
Professional Services Agreement between Christopher J. Wllace and Tauriga Sciences, Inc., dated September 24, 2020
(Filed With SEC on October 1, 2020)
-
Professional Services Agreement between Willie C. Mack, Jr. and Tauriga Sciences, Inc., dated September 24, 2020
(Filed With SEC on October 1, 2020)
-
Amended Collaboration agreement with Aegea Biotechnologies Inc. dated August 10, 2020
(Filed With SEC on August 14, 2020)
-
Product Placement Membership Agreement between the Company and KushCo Holdings, Inc., dated July 10, 2020
(Filed With SEC on July 14, 2020)
-
Convertible Note between the Company and GS Capital LLC dated June 4, 2020
(Filed With SEC on July 14, 2020)
-
Securities Purchase Agreement between the Company and GS Capital LLC dated June 4, 2020
(Filed With SEC on July 14, 2020)
-
Form of Securities Purchase agreement between Aegea Biotechnologies, Inc
(Filed With SEC on June 29, 2020)
-
Tangiers Global, LLC 8% Fixed Convertible Note for $210,000 dated June 24, 2020
(Filed With SEC on June 29, 2020)
-
Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 filed on Current Report 8-K on May 3, 2019
(Filed With SEC on June 29, 2020)
-
Warrant Subscription Agreement with VistaGen Therapeutics, Inc. dated December 6, 2019
(Filed With SEC on June 29, 2020)
-
Convertible Note between the Company and Adar Alef, LLC, dated April 30, 2020
(Filed With SEC on June 3, 2020)
-
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated April 30, 2020
(Filed With SEC on June 3, 2020)
-
Convertible Note between the Company and GS Capital LLC dated April 17, 2020
(Filed With SEC on June 3, 2020)
-
Securities Purchase Agreement between the Company and GS Capital LLC dated April 17, 2020
(Filed With SEC on June 3, 2020)
-
Convertible Note between the Company and Tangiers Global, LLC dated March 23, 2020
(Filed With SEC on June 3, 2020)
-
Convertible Note between the Company and Firstfire Global Opportunities Fund, LLC dated May 18, 2020
(Filed With SEC on June 3, 2020)
-
Securities Purchase Agreement between the Company and Firstfire Global Opportunities Fund, LLC dated May 18, 2020
(Filed With SEC on June 3, 2020)
-
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated March 17, 2020
(Filed With SEC on April 15, 2020)
-
Collaboration Agreement with Aegea Biotechnologies Inc. dated April 3, 2020
(Filed With SEC on April 15, 2020)
-
Convertible Note between the Company and Adar Alef, LLC, dated March 17, 2020
(Filed With SEC on April 15, 2020)
-
Convertible Note between the Company and Tangiers Global, LLC dated March 23, 2020
(Filed With SEC on April 15, 2020)
-
Amended and Restated 10% Fixed Convertible Promissory Note in the principal amount of $137,500 dated February 28, 2020
(Filed With SEC on March 5, 2020)
-
Crown Bridge Partners, LLC $55,000 one-year 10% Convertible Promissory Note dated February 11, 2020
(Filed With SEC on March 5, 2020)
-
Securities Purchase Agreement between the Company and Adar Alef, LLC, dated January 15, 2020
(Filed With SEC on February 13, 2020)
-
Convertible Note between the Company and Adar Alef, LLC, dated January 15, 2020
(Filed With SEC on February 13, 2020)
-
Tangiers Global, LLC 10% Convertible Promissory Note effective February 7, 2020
(Filed With SEC on February 13, 2020)
-
Investment Agreement between Tangiers Global, LLC and the Company, dated January 21, 2020
(Filed With SEC on January 29, 2020)
-
Convertible Note between the Company and GS Capital Partners, dated January 17, 2020
(Filed With SEC on January 29, 2020)
-
Securities Purchase Agreement between the Company and GS Capital Partner, dated January 17, 2020
(Filed With SEC on January 29, 2020)
-
Registration Rights Agreement, dated January 21, 2020
(Filed With SEC on January 29, 2020)
-
Convertible Promissory Note issued to BHP Capital NY Inc., dated January 3, 2020
(Filed With SEC on January 9, 2020)
-
Securities Purchase Agreement between BHP Capital NY INC and the Company, dated January 3, 2020
(Filed With SEC on January 9, 2020)
-
Securities Purchase Agreement, December 2019 private placement
(Filed With SEC on January 9, 2020)
-
Convertible Redeemable Note issued to Jefferson Street Capital LLC, dated December 26, 2019
(Filed With SEC on January 9, 2020)
-
Securities Purchase Agreement between Jefferson Street Capital LLC and the Company, dated December 26, 2019
(Filed With SEC on January 9, 2020)
-
Convertible Redeemable Note issued to Odyssey Capital, LLC, dated December 18, 2019
(Filed With SEC on January 9, 2020)
-
Securities Purchase Agreement between Odyssey Capital, LLC and the Company, dated December 18, 2019
(Filed With SEC on January 9, 2020)
-
Tangiers Global, LLC 10% Convertible Promissory Note dated November 5, 2019
(Filed With SEC on November 12, 2019)
-
BHP Capital NY, Inc Convertible Promissory note dated October 17, 2019
(Filed With SEC on November 12, 2019)
-
BHP Capital NY, Inc. Securities Purchase Agreement dated October 7, 2019
(Filed With SEC on November 12, 2019)
-
Securities Purchase Agreement between Odyssey Funding, LLC and the Company, dated September 13, 2019
(Filed With SEC on October 8, 2019)
-
Convertible Redeemable Note issued to Odyssey Funding, LLC, dated September 13, 2019
(Filed With SEC on October 8, 2019)
-
Agreement with Vice President of Distribution & Marketing date May 11, 2019
(Filed With SEC on August 13, 2019)
-
Jefferson St. Capital, LLC Convertible note dated July 22, 2019 for $55,000
(Filed With SEC on August 13, 2019)
-
Jefferson St. Capital LLC Securities Purchase Agreement note dated July 22, 2019 for $55,000
(Filed With SEC on August 13, 2019)
-
Distribution Agreement between the Company and Windmill Health Products, LLC, dated June 28, 2019
(Filed With SEC on July 5, 2019)
-
GS Capital Partners, LLC Securities Purchase Agreement dated June 21, 2019
(Filed With SEC on June 27, 2019)
-
GS Capital Partners, LLC Convertible note dated March 14, 2019 for $300,000
(Filed With SEC on June 27, 2019)
-
GS Capital Partners, LLC Securities Purchase Agreement dated March 14, 2019
(Filed With SEC on June 27, 2019)
-
GS Capital Partners, LLC Securities Purchase Agreement dated May 23, 2019
(Filed With SEC on June 27, 2019)
-
GS Capital, LLC Convertible note dated May 23, 2019 for $60,000
(Filed With SEC on June 27, 2019)
-
GS Capital Partners, LLC Convertible note dated June 21, 2019 for $60,000
(Filed With SEC on June 27, 2019)
-
Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019
(Filed With SEC on May 3, 2019)
-
Securities Purchase Agreement (GS Capital Note), dated March 14, 2019
(Filed With SEC on April 15, 2019)
-
Distribution Agreement between the Company and E&M Ice Cream Co., dated April 1, 2019
(Filed With SEC on April 15, 2019)
-
Distribution Agreement between the Company and IRM Management Corporation, dated April 8, 2019
(Filed With SEC on April 15, 2019)
-
GS Capital Note, dated March 14, 2019
(Filed With SEC on April 15, 2019)
-
SECURITIES PURCHASE AGREEMENT Tauriga Sciences Inc. (OTCQB: TAUG) 555 Madison Avenue, 5th Floor New York, NY 10022 Attn: Seth M. Shaw, Chief Executive Officer. DATE: March ____,...
(Filed With SEC on April 15, 2019)
-
Securities Purchase Agreement with Eagle Equities LLC consummated January 23, 2019 concerning the $62,000 convertible note
(Filed With SEC on January 29, 2019)
-
Securities purchase agreement dated January 8, 2019 for 1,000,000 shares at $0.02
(Filed With SEC on January 29, 2019)
-
January 11, 2019 consulting agreement for 1,250,000 restricted common shares
(Filed With SEC on January 29, 2019)
-
Manufacturing agreement with Per Os Biosciences dated December 28, 2018
(Filed With SEC on January 29, 2019)
-
Collateralized secured promissory note from Adar Alef dated December 20, 2019
(Filed With SEC on January 29, 2019)
-
One year 8% Convertible back-end note with Adar Alef dates December 20, 2018
(Filed With SEC on January 29, 2019)
-
One year 8% Convertible note with Adar Alef dates December 20, 2018
(Filed With SEC on January 29, 2019)
-
Securities purchase agreement with Adar Alef dates December 20, 2018
(Filed With SEC on January 29, 2019)
-
Side letter agreement dated January 18, 2019 to the $62,000 Convertible note with Eagle Equities LLC consummated January 23,2019
(Filed With SEC on January 29, 2019)
-
Convertible note consummated January 23, 2019 for $62,000 with Eagle Equities LLC
(Filed With SEC on January 29, 2019)